Arcus Biosciences (RCUS) Operating Expenses: 2017-2025
Historic Operating Expenses for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to $168.0 million.
- Arcus Biosciences' Operating Expenses rose 9.80% to $168.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $615.0 million, marking a year-over-year increase of 5.85%. This contributed to the annual value of $588.0 million for FY2024, which is 28.67% up from last year.
- Per Arcus Biosciences' latest filing, its Operating Expenses stood at $168.0 million for Q3 2025, which was down 0.00% from $168.0 million recorded in Q2 2025.
- Arcus Biosciences' 5-year Operating Expenses high stood at $168.0 million for Q2 2025, and its period low was $73.6 million during Q4 2021.
- Over the past 3 years, Arcus Biosciences' median Operating Expenses value was $145.0 million (recorded in 2024), while the average stood at $139.2 million.
- As far as peak fluctuations go, Arcus Biosciences' Operating Expenses skyrocketed by 172.66% in 2021, and later dropped by 6.83% in 2025.
- Quarterly analysis of 5 years shows Arcus Biosciences' Operating Expenses stood at $73.6 million in 2021, then spiked by 46.74% to $108.0 million in 2022, then rose by 12.96% to $122.0 million in 2023, then climbed by 5.74% to $129.0 million in 2024, then grew by 9.80% to $168.0 million in 2025.
- Its last three reported values are $168.0 million in Q3 2025, $168.0 million for Q2 2025, and $150.0 million during Q1 2025.